Effect of atilmotin, a motilin receptor agonist, on esophageal, lower esophageal sphincter, and gastric pressures

Digestive Diseases and Sciences

Volumn 55, Issue 2, 2010, Pages 300-306

  Korimilli, Annapurna ^a   Parkman, Henry P ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Esophageal manometry; Lower esophageal sphincter; Motilin

Indexed keywords

ATILMOTIN; HORMONE RECEPTOR STIMULATING AGENT; MOTILIN; PLACEBO; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ESOPHAGUS MANOMETRY; ESOPHAGUS PRESSURE; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; STOMACH PRESSURE; THORAX PAIN; ADOLESCENT; CONTROLLED CLINICAL TRIAL; DRUG POTENTIATION; ESOPHAGUS; FOLLOW UP; GASTROINTESTINAL MOTILITY; INTRAVENOUS DRUG ADMINISTRATION; MANOMETRY; MIDDLE AGED; PHYSIOLOGY; PRESSURE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STOMACH;

ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL MOTILITY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MANOMETRY; MIDDLE AGED; MOTILIN; PEPTIDE FRAGMENTS; PRESSURE; REFERENCE VALUES; SINGLE-BLIND METHOD; STOMACH; YOUNG ADULT;

EID: 76849102124     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1056-1     Document Type: Article

References (18)

1. Z Itoh M Nakaya T Suzuki H Arai K Wakabayashi 1984 Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog Am J Physiol 247 6 Pt 1 G688 G694 1:CAS:528:DyaL2MXnt1Cluw%3D%3D 6507625
2. MJ Macielag TL Peeters ZD Konteatis JR Florance I Depoortere RA Lessor LA Bare YS Cheng A Galdes 1992 Synthesis and in vitro evaluation of [Leu13] porcine motilin fragments Peptides 13 3 565 569 10.1016/0196-9781(92)90090-P 1:CAS:528:DyaK38XltVCnsr0%3D 1523168
3. M-I Park I Ferber M Camilleri K Allenby R Trillo D Burton AR Zinsmeister 2006 Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study Neurogastroenterol Motil 18 28 36 10.1111/j.1365-2982.2005.00726.x 16371080
4. Baxter Healthcare Corporation. BAX-ACC-1638 Injection Clinical Investigator's Brochure. 2003;Ed1:Vers2.
5. G Lux W Rosch S Domschke, et al. 1976 Intravenous 13-Nle-motilin increases the human lower esophageal sphincter pressure Scand J Gastroent 11 Suppl 39 75 79 1:CAS:528:DyaE2sXhtFGmt7s%3D
6. HP Parkman DL Miller, et al. 1996 Optimal evaluation of esophageal dysphagia: esophageal manometry, esophageal transit scintigraphy or videoesophagography Dig Dis Sci 41 7 1355 1368 10.1007/BF02088560 1:STN:280:DyaK28zhtVyhtQ%3D%3D 8689912 (Pubitemid 26245916)
7. I Hirano J Pandolfino 2007 New technologies for the evaluation of esophageal motility disorders: impedance, high-resolution manometry, and intraluminal ultrasound Gastroenterol Clin North Am 36 3 531 551 10.1016/j.gtc.2007.07.005 17950437 (Pubitemid 47577498)
8. JE Pandolfino SK Ghosh J Rice JO Clarke MA Kwiatek PJ Kahrilas 2008 Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls Am J Gastroenterol 103 1 27 37 17900331
9. J Janssens TL Peeters J VanTrappen, et al. 1990 Improvement of gastric emptying in diabetic gastroparesis by erythromycin NEJM 322 15 1028 1031 1:STN:280:DyaK3c3gsF2rsw%3D%3D 2320062
10. RW McCallum O Cynshi 2007 Investigative team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis-a randomized, multicentre, placebo-controlled study Aliment Pharmacol Ther 26 8 1121 1130 1:CAS:528:DC%2BD2sXhtlaksL%2FI 17894654
11. NJ Talley M Verlinden W Snape JA Beker P Ducrotte A Dettmer H Brinkhoff E Eaker G Ohning PB Miner JR Mathias I Fumagalli D Staessen RJ Mack 2000 Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial Aliment Pharmacol Ther 14 12 1653 1661 10.1046/j.1365-2036.2000.00868.x 1:CAS:528:DC%2BD3MXkvVOrtA%3D%3D 11121915 (Pubitemid 32011739)
12. S Chaussade S Michopoulos P Sogni J Guerre D Couturier 1994 Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nerves Dig Dis Sci 39 381 384 10.1007/BF02090212 1:CAS:528:DyaK2cXkslemtr8%3D 8313822
13. AJ Meissner KL Bowes R Zwick EE Daniel 1976 Effect of motilin on the lower oesophageal sphincter Gut 17 925 932 10.1136/gut.17.12.925 1:CAS:528:DyaE2sXhvVelsb4%3D 1017712
14. G Tzovaras E Xynos E Chrysos A Mantides JS Vassilakis 1996 The effect of intravenous erythromycin on esophageal motility in healthy subjects Am J Surg 171 316 319 10.1016/S0002-9610(97)89633-X 1:CAS:528:DyaK28XitlKqt7w%3D 8615464 (Pubitemid 26086698)
15. E Chrysos G Tzovaras E Epanomeritakis J Tsiaoussis N Vrachasotakis JS Vassilakis E Xynos 2001 Erythromycin enhances oesophageal motility in patients with gastro-oesophageal reflux ANZ J Surg 71 2 98 102 10.1046/j.1440-1622.2001. 02005.x 1:STN:280:DC%2BD3MzltVWrtA%3D%3D 11413601 (Pubitemid 32171622)
16. A Pennathur A Tran M Cioppi J Fayad GL Sieren AG Little 1994 Erythromycin strengthens the defective lower esophageal sphincter in patients with gastroesophageal reflux disease Am J Surg 167 169 172 10.1016/0002-9610(94) 90069-8 1:STN:280:DyaK2c7ksVOjsA%3D%3D 8311129
17. P Netzer B Schmitt W Inauen 2002 Effects of ABT-229, a motilin agonist, on acid reflux, oesophageal motility and gastric emptying in patients with gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 1481 1490 10.1046/j.1365-2036.2002.01324.x 1:CAS:528:DC%2BD38XnsVSkt78%3D 12182748 (Pubitemid 34953589)
18. MA van Herwaarden M Samsom CH van Nispen M Verlinden AJ Smout 2000 The effect of motiin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients Aliment Pharmacol Ther 14 453 462 10.1046/j.1365-2036.2000.00712.x 10759625 (Pubitemid 30199222)